{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:07:44Z","timestamp":1788473264644,"version":"build-2803163510"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,1,5]],"date-time":"2014-01-05T00:00:00Z","timestamp":1388880000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s12035-013-8618-0","type":"journal-article","created":{"date-parts":[[2014,1,4]],"date-time":"2014-01-04T10:19:12Z","timestamp":1388830752000},"page":"358-367","source":"Crossref","is-referenced-by-count":21,"title":["Coadministration of Branched-Chain Amino Acids and Lipopolysaccharide Causes Matrix Metalloproteinase Activation and Blood\u2013Brain Barrier Breakdown"],"prefix":"10.1007","volume":"50","author":[{"given":"Giselli","family":"Scaini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meline O. S.","family":"Morais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia S.","family":"Galant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francieli","family":"Vuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dh\u00e9bora M.","family":"Dall\u2019Igna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matheus A. B.","family":"Pasquali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor M.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Gelain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Claudio F.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia F.","family":"Schuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo C.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco G.","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Dal-Pizzol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio L.","family":"Streck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,1,5]]},"reference":[{"key":"8618_CR1","first-page":"1971","volume-title":"The metabolic and molecular bases of inherited disease","author":"DT Chuang","year":"2001","unstructured":"Chuang DT, Shih VE (2001) Maple syrup urine disease (branchedchain ketoaciduria). In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 1971\u20132005"},{"key":"8618_CR2","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1542\/peds.34.4.454","volume":"34","author":"SE Snyderman","year":"1964","unstructured":"Snyderman SE, Norton PM, Roitman E, Holt LE Jr (1964) Maple syrup urine disease, with particular reference to dietotherapy. Pediatrics 34:454\u2013472","journal-title":"Pediatrics"},{"key":"8618_CR3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-3-642-68970-3_5","volume":"8","author":"A Gjedde","year":"1983","unstructured":"Gjedde A, Crone C (1983) Biochemical modulation of blood\u2013brain barrier permeability. Acta Neuropathol Suppl (Berl) 8:59\u201374","journal-title":"Acta Neuropathol Suppl (Berl)"},{"key":"8618_CR4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1749-6632.1986.tb27150.x","volume":"481","author":"QR Smith","year":"1986","unstructured":"Smith QR, Takasato Y (1986) Kinetics of amino acid transport at the blood\u2013brain barrier studied using an in situ brain perfusion technique. Ann N Y Acad Sci 481:186\u2013201","journal-title":"Ann N Y Acad Sci"},{"key":"8618_CR5","doi-asserted-by":"crossref","first-page":"12079","DOI":"10.1073\/pnas.96.21.12079","volume":"96","author":"RJ Boado","year":"1999","unstructured":"Boado RJ, Li JY, Nagaya M, Zhang C, Pardridge WM (1999) Selective expression of the large neutral amino acid transporter at the blood\u2013brain barrier. Proc Natl Acad Sci U S A 96:12079\u201312084","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8618_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3940(01)01810-9","volume":"306","author":"DM Killian","year":"2001","unstructured":"Killian DM, Chikhale PJ (2001) Predominant functional activity of the large, neutral amino acid transporter (LAT1) isoform at the cerebrovasculature. Neurosci Lett 306:1\u20134","journal-title":"Neurosci Lett"},{"key":"8618_CR7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0887-8994(92)90038-Z","volume":"8","author":"A Kamei","year":"1992","unstructured":"Kamei A, Takashima S, Chan F, Becker LE (1992) Abnormal dendritic development in maple syrup urine disease. Pediatr Neurol 8:145\u2013147","journal-title":"Pediatr Neurol"},{"key":"8618_CR8","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0197-0186(00)00100-5","volume":"38","author":"P Ara\u00fajo","year":"2001","unstructured":"Ara\u00fajo P, Wassermann GF, Tallini K et al (2001) Reduction of large neutral amino acid levels in plasma and brain of hyperleucinemic rats. Neurochem Int 38:529\u2013537","journal-title":"Neurochem Int"},{"key":"8618_CR9","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/brain\/awp024","volume":"132","author":"WJ Zinnanti","year":"2009","unstructured":"Zinnanti WJ, Lazovic J, Griffin K et al (2009) Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease. Brain 132:903\u2013918","journal-title":"Brain"},{"key":"8618_CR10","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1471-4159.1966.tb05882.x","volume":"13","author":"AL Prensky","year":"1966","unstructured":"Prensky AL, Moser HW (1966) Brain lipids, proteolipids, and free amino acids in maple syrup urine disease. J Neurochem 13:863\u2013874","journal-title":"J Neurochem"},{"key":"8618_CR11","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1471-4159.1992.tb09409.x","volume":"59","author":"PR Dodd","year":"1992","unstructured":"Dodd PR, Williams SH, Gundlach AL et al (1992) Glutamate and gamma-aminobutyric acid neurotransmitter systems in the acute phase of maple syrup urine disease and citrullinemia encephalopathies in newborn calves. J Neurochem 59:582\u2013590","journal-title":"J Neurochem"},{"key":"8618_CR12","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3181\/00379727-113-28456","volume":"113","author":"RK Howell","year":"1963","unstructured":"Howell RK, Lee M (1963) Influence of a-keto acids on the respiration of brain in vitro. Proc Soc Exp Biol Med 113:660\u2013663","journal-title":"Proc Soc Exp Biol Med"},{"key":"8618_CR13","first-page":"671","volume-title":"The metabolic basis of inherited disease","author":"DJ Danner","year":"1989","unstructured":"Danner DJ, Elsas LJ (1989) Disorders of branched chain amino acid and keto acid metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease. McGraw-Hill, New York, pp 671\u2013692"},{"key":"8618_CR14","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1023\/A:1022876130038","volume":"28","author":"C Pilla","year":"2003","unstructured":"Pilla C, Cardozo RF, Dutra-Filho CS, Wyse AT, Wajner M, Wannmacher CM (2003) Creatine kinase activity from rat brain is inhibited by branched-chain amino acids in vitro. Neurochem Res 28:675\u2013679","journal-title":"Neurochem Res"},{"key":"8618_CR15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bbadis.2003.09.010","volume":"1639","author":"AM Sgaravati","year":"2003","unstructured":"Sgaravati AM, Rosa RB, Schuck PF et al (2003) Inhibition of brain energy metabolism by the a-keto acids accumulating in maple syrup urine disease. Biochim Biophys Acta 1639:232\u2013238","journal-title":"Biochim Biophys Acta"},{"key":"8618_CR16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s11064-007-9423-9","volume":"33","author":"CA Ribeiro","year":"2008","unstructured":"Ribeiro CA, Sgaravatti AM, Rosa R et al (2008) Inhibition of brain energy metabolism by the branched-chain amino acids accumulating in maple syrup urine disease. Neurochem Res 33:114\u2013124","journal-title":"Neurochem Res"},{"key":"8618_CR17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.brainres.2010.02.018","volume":"1324","author":"AU Amaral","year":"2010","unstructured":"Amaral AU, Leipnitz G, Fernandes CG, Seminotti B, Schuck PF, Wajner M (2010) Alpha-ketoisocaproic acid and leucine provoke mitochondrial bioenergetic dysfunction in rat brain. Brain Res 1324:75\u201384","journal-title":"Brain Res"},{"key":"8618_CR18","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s11064-012-0961-4","volume":"38","author":"ID Franceschi de","year":"2013","unstructured":"de Franceschi ID, Rieger E, Vargas AP et al (2013) Effect of leucine administration to female rats during pregnancy and lactation on oxidative stress and enzymes activities of phosphoryltransfer network in cerebral cortex and hippocampus of the offspring. Neurochem Res 38:632\u2013643","journal-title":"Neurochem Res"},{"key":"8618_CR19","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1091\/mbc.11.5.1919","volume":"11","author":"J Jouvet","year":"2000","unstructured":"Jouvet J, Rustin P, Taylor DL et al (2000) Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane depolarization or cytochrome c release: implications for neurological impairment associated with maple syrup urine disease. Mol Biol Cell 11:1919\u20131932","journal-title":"Mol Biol Cell"},{"key":"8618_CR20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0736-5748(03)00074-1","volume":"21","author":"R Bridi","year":"2003","unstructured":"Bridi R, Araldi J, Sgarbi MB et al (2003) Induction of oxidative stress in rat brain by the metabolites accumulating in maple syrup urine disease. Int J Dev Neurosci 21:327\u2013332","journal-title":"Int J Dev Neurosci"},{"key":"8618_CR21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/10715760400022350","volume":"39","author":"R Bridi","year":"2005","unstructured":"Bridi R, Latini A, Braun CA et al (2005) Evaluation of the mechanisms involved in leucine induced oxidative damage in cerebral cortex of young rats. Free Radic Res 39:71\u201379","journal-title":"Free Radic Res"},{"key":"8618_CR22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/A:1014004414733","volume":"17","author":"FU Fontella","year":"2002","unstructured":"Fontella FU, Gassen E, Pulrolni V et al (2002) Stimulation of lipid peroxidation in vitro in rat brain by the metabolites accumulating in maple syrup urine disease. Metab Brain Dis 17:47\u201354","journal-title":"Metab Brain Dis"},{"key":"8618_CR23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11011-006-9030-5","volume":"21","author":"AG Barschak","year":"2006","unstructured":"Barschak AG, Sitta A, Deon M et al (2006) Evidence that oxidative stress in increased in plasma from pacients with maple syrup urine disease. Metab Brain Dis 21:279\u2013286","journal-title":"Metab Brain Dis"},{"key":"8618_CR24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11011-011-9238-x","volume":"26","author":"C Mescka","year":"2011","unstructured":"Mescka C, Moraes T, Rosa A et al (2011) In vivo neuroprotective effect of l-carnitine against oxidative stress in maple syrup urine disease. Metab Brain Dis 26:21\u201328","journal-title":"Metab Brain Dis"},{"key":"8618_CR25","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s12035-012-8243-3","volume":"45","author":"G Scaini","year":"2012","unstructured":"Scaini G, de Rochi N, Jeremias IC et al (2012) Evaluation of acetylcholinesterase in an animal model of maple syrup urine disease. Mol Neurobiol 45:279\u2013286","journal-title":"Mol Neurobiol"},{"key":"8618_CR26","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s10545-012-9549-z","volume":"36","author":"G Scaini","year":"2013","unstructured":"Scaini G, Comim CM, Oliveira GM et al (2013) Chronic administration of branched-chain amino acids impairs spatial memory and increases brain-derived neurotrophic factor in a rat model. J Inherit Metab Dis 36:721\u2013730","journal-title":"J Inherit Metab Dis"},{"key":"8618_CR27","author":"G Scaini","year":"2013","unstructured":"Scaini G, Mello-Santos LM, Furlanetto CB et al (2013) Acute and chronic administration of the branched-chain amino acids decreases nerve growth factor in rat hippocampus. Mol Neurobiol. doi: 10.1007\/s12035-013-8447-1","journal-title":"Mol Neurobiol"},{"key":"8618_CR28","first-page":"E1052","volume":"273","author":"M Holecek","year":"1997","unstructured":"Holecek M, Sprongl L, Skopec F, Andr\u00fds C, Pecka M (1997) Leucine metabolism in TNF-alpha- and endotoxin-treated rats: contribution of hepatic tissue. Am J Physiol 273:E1052\u2013E1058","journal-title":"Am J Physiol"},{"key":"8618_CR29","first-page":"R419","volume":"266","author":"Y Fong","year":"1994","unstructured":"Fong Y, Matthews DE, He W, Marano MA, Moldawer LL, Lowry SF (1994) Whole body and splanchnic leucine, phenylalanine, and glucose kinetics during endotoxemia in humans. Am J Physiol 266:R419\u2013R425","journal-title":"Am J Physiol"},{"key":"8618_CR30","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0026-0495(98)90030-0","volume":"47","author":"M Holecek","year":"1998","unstructured":"Holecek M, Sprongl L, Tich\u00fd M, Pecka M (1998) Leucine metabolism in rat liver after a bolus injection of endotoxin. Metabolism 47:681\u2013685","journal-title":"Metabolism"},{"key":"8618_CR31","first-page":"98","volume":"79","author":"JR Marshall","year":"1979","unstructured":"Marshall JR, Gracy RW, Kester MV (1979) Maple syrup urine disease: response to dietary modifications. J Am Osteopath Assoc 79:98","journal-title":"J Am Osteopath Assoc"},{"key":"8618_CR32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.nbd.2009.07.031","volume":"37","author":"WA Banks","year":"2010","unstructured":"Banks WA, Erickson MA (2010) The blood\u2013brain barrier and immune function and dysfunction. Neurobiol Dis 37:26\u201332","journal-title":"Neurobiol Dis"},{"key":"8618_CR33","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0197-4580(01)00287-1","volume":"22","author":"RE Mrak","year":"2001","unstructured":"Mrak RE, Griffin WS (2001) Interleukin-1, neuroinflammation, and Alzheimer\u2019s disease. Neurobiol Aging 22:903\u2013908","journal-title":"Neurobiol Aging"},{"key":"8618_CR34","doi-asserted-by":"crossref","first-page":"5812","DOI":"10.4049\/jimmunol.178.9.5812","volume":"178","author":"MC Marcondes","year":"2007","unstructured":"Marcondes MC, Burdo TH, Sopper S et al (2007) Enrichment and persistence of virus-specific CTL in the brain of simian immunodeficiency virus-infected monkeys is associated with a unique cytokine environment. J Immunol 178:5812\u20135819","journal-title":"J Immunol"},{"key":"8618_CR35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cellimm.2007.09.010","volume":"252","author":"JC O\u2019Connor","year":"2008","unstructured":"O\u2019Connor JC, McCusker RH, Strle K, Johnson RW, Dantzer R, Kelley KW (2008) Regulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinology. Cell Immunol 252:91\u2013110","journal-title":"Cell Immunol"},{"key":"8618_CR36","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/archneurol.2009.27","volume":"66","author":"S Craft","year":"2009","unstructured":"Craft S (2009) The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. Arch Neurol 66:300\u2013305","journal-title":"Arch Neurol"},{"key":"8618_CR37","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2174\/138955709789055199","volume":"9","author":"M Reale","year":"2009","unstructured":"Reale M, Greig NH, Kamal MA (2009) Peripheral chemo-cytokine profiles in Alzheimer\u2019s and Parkinson\u2019s diseases. Mini-Rev Med Chem 9:1229\u20131241","journal-title":"Mini-Rev Med Chem"},{"key":"8618_CR38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0306-4522(02)00030-1","volume":"112","author":"MI Combrinck","year":"2002","unstructured":"Combrinck MI, Perry VH, Cunningham C (2002) Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease. Neuroscience 112:7\u201311","journal-title":"Neuroscience"},{"key":"8618_CR39","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bbi.2009.01.017","volume":"23","author":"LB Jaeger","year":"2009","unstructured":"Jaeger LB, Dohgu S, Sultana R et al (2009) Lipopolysaccharide alters the blood\u2013brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer\u2019s disease. Brain Behav Immun 23:507\u2013517","journal-title":"Brain Behav Immun"},{"key":"8618_CR40","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10571-004-1374-y","volume":"25","author":"NJ Abbott","year":"2005","unstructured":"Abbott NJ (2005) Dynamics of CNS barriers: evolution, differentiation, and modulation. Cell Mol Neurobiol 25:5\u201323","journal-title":"Cell Mol Neurobiol"},{"key":"8618_CR41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1146\/annurev.neuro.22.1.11","volume":"22","author":"LL Rubin","year":"1999","unstructured":"Rubin LL, Staddon JM (1999) The cell biology of the blood brain barrier. Annu Rev Neurosci 22:11\u201328","journal-title":"Annu Rev Neurosci"},{"key":"8618_CR42","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1006\/scdb.2000.0178","volume":"11","author":"L Gonzalez-Mariscal","year":"2000","unstructured":"Gonzalez-Mariscal L, Betanzos A, Avila-Flores A (2000) MAGUK proteins: structure and role in the tight junction. Semin Cell Dev Biol 11:315\u2013324","journal-title":"Semin Cell Dev Biol"},{"key":"8618_CR43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0006-8993(92)90681-X","volume":"576","author":"GA Rosenberg","year":"1992","unstructured":"Rosenberg GA, Kornfeld M, Estrada M, Kelley RO, Liotta LA, Stetler-Stevenson WG (1992) TIMP-2 reduces proteolytic opening of blood\u2013brain barrier by type-IV collagenase. Brain Res 576:203\u2013207","journal-title":"Brain Res"},{"key":"8618_CR44","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0006-8993(95)01089-0","volume":"703","author":"GA Rosenberg","year":"1995","unstructured":"Rosenberg GA, Estrada EY, Dencoff JE, Stetler-Stevenson WG (1995) Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood\u2013brain barrier: an expanded therapeutic window. Brain Res 703:151\u2013155","journal-title":"Brain Res"},{"key":"8618_CR45","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/neu.1990.7.207","volume":"7","author":"RJ Schoettle","year":"1990","unstructured":"Schoettle RJ, Kochanek PM, Magargee MJ, Uhl MW, Nemoto EM (1990) Early polymorphonuclear leukocyte accumulation correlates with the development of posttraumatic cerebral edema in rats. J Neurotrauma 7:207\u2013217","journal-title":"J Neurotrauma"},{"key":"8618_CR46","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1098\/rstb.2003.1358","volume":"358","author":"SM Allan","year":"2005","unstructured":"Allan SM, Rothwell NJ (2005) Inflammation in central nervous system injury. Philos Trans R Soc Lond Biol Sci 358:1669\u20131677","journal-title":"Philos Trans R Soc Lond Biol Sci"},{"key":"8618_CR47","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00004647-200002000-00019","volume":"20","author":"PF Stahel","year":"2000","unstructured":"Stahel PF, Shohami E, Younis FM et al (2000) Experimental closed head injury: analysis of neurological outcome, blood\u2013brain barrier dysfunction, intra-cranial neutrophil infiltration, and neuronal cell death in mice deficient in genes for pro-inflammatory cytokines. J Cereb Blood Flow Metab 20:369\u2013380","journal-title":"J Cereb Blood Flow Metab"},{"key":"8618_CR48","doi-asserted-by":"crossref","first-page":"S232","DOI":"10.1038\/sj.bjp.0706400","volume":"147","author":"SM Lucas","year":"2006","unstructured":"Lucas SM, Rothwell NJ, Gibson RM (2006) The role of inflammation in CNS injury and disease. Brit J Pharmacol 147:S232\u2013S240","journal-title":"Brit J Pharmacol"},{"key":"8618_CR49","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.bbi.2011.06.006","volume":"25","author":"MA Erickson","year":"2011","unstructured":"Erickson MA, Banks WA (2011) Cytokine and chemokine responses in serum and brain after single and repeated injections of lipopolysaccharide: multiplex quantification with path analysis. Brain Behav Immun 25:1637\u20131648","journal-title":"Brain Behav Immun"},{"key":"8618_CR50","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jneumeth.2006.01.005","volume":"155","author":"R Bridi","year":"2006","unstructured":"Bridi R, Fontella FU, Pulrolnik V et al (2006) A chemically-induced acute model of maple syrup urine disease in rats for neurochemical studies. J Neurosci Methods 155:224\u2013230","journal-title":"J Neurosci Methods"},{"key":"8618_CR51","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/jcbfm.1988.59","volume":"8","author":"O Uyama","year":"1988","unstructured":"Uyama O, Okamura N, Yanase M, Narita M, Kawabata K, Sugita M (1988) Quantitative evaluation of vascular permeability in the gerbil brain after transient ischemia using evans blue fluorescence. J Cereb Blood Flow Metab 8:282\u2013284","journal-title":"J Cereb Blood Flow Metab"},{"key":"8618_CR52","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1203\/PDR.0b013e318123fb7c","volume":"62","author":"RS Coimbra","year":"2007","unstructured":"Coimbra RS, Loquet G, Leib SL (2007) Limited efficacy of adjuvant therapy with dexamethasone in preventing hearing loss due to experimental pneumococcal meningitis in the infant rat. Pediatr Res 62:291\u2013294","journal-title":"Pediatr Res"},{"key":"8618_CR53","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0006-8993(96)00815-3","volume":"739","author":"L Belayev","year":"1996","unstructured":"Belayev L, Busto R, Zhao W, Ginsberg MD (1996) Quantitative evaluation of blood\u2013brain barrier permeability following middle cerebral artery occlusion in rats. Brain Res 739:88\u201396","journal-title":"Brain Res"},{"key":"8618_CR54","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.bbrc.2005.11.133","volume":"339","author":"T Kago","year":"2006","unstructured":"Kago T, Takagi N, Date I, Takenaga Y, Takagi K, Takeo S (2006) Cerebral ischemia enhances tyrosine phosphorylation of occludin in brain capillaries. Biochem Biophys Res Commun 339:1197\u20131203","journal-title":"Biochem Biophys Res Commun"},{"key":"8618_CR55","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","volume":"37","author":"NJ Abbott","year":"2010","unstructured":"Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ (2010) Structure and function of the blood\u2013brain barrier. Neurobiol Dis 37:13\u201325","journal-title":"Neurobiol Dis"},{"key":"8618_CR56","first-page":"2065","volume":"45","author":"EM Cornford","year":"1986","unstructured":"Cornford EM, Cornford ME (1986) Nutrient transport and the blood\u2013brain barrier in developing animals. Fed Proc 45:2065\u20132072","journal-title":"Fed Proc"},{"key":"8618_CR57","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1469-8749.1978.tb15223.x","volume":"20","author":"G Banos","year":"1978","unstructured":"Banos G, Daniel PM, Pratt OE (1978) The effect of age upon the entry of some amino acids into the brain, and their incorporation into cerebral protein. Dev Med Child Neurol 20:335\u2013346","journal-title":"Dev Med Child Neurol"},{"key":"8618_CR58","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1161\/01.STR.29.5.1020","volume":"29","author":"AM Romanic","year":"1998","unstructured":"Romanic AM, White RF, Arleth AJ, Ohlstein EH, Barone FC (1998) Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 29:1020\u20131030","journal-title":"Stroke"},{"key":"8618_CR59","doi-asserted-by":"crossref","first-page":"H558","DOI":"10.1152\/ajpheart.01275.2004","volume":"289","author":"JM Gidday","year":"2005","unstructured":"Gidday JM, Gasche YG, Copin JC, Shah AR, Perez RS, Shapiro SD, Chan PH, Park TS (2005) Leukocyte-derived matrix metalloproteinase-9 mediates blood\u2013brain barrier breakdown and is pro-inflammatory after transient focal cerebral ischemia. Am J Physiol Heart Circ Physiol 289:H558\u2013H568","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"8618_CR60","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrm2125","volume":"8","author":"A Page-McCaw","year":"2007","unstructured":"Page-McCaw A, Ewald AJ, Werb Z (2007) Matrix metalloproteinases and the regulation of tissue remodeling. Nat Rev Mol Cell Biol 8:221\u2013233","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8618_CR61","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1212\/WNL.48.4.921","volume":"48","author":"GA Rosenberg","year":"1997","unstructured":"Rosenberg GA, Navratil M (1997) Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat. Neurology 48:921\u2013992","journal-title":"Neurology"},{"key":"8618_CR62","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/brain\/120.3.435","volume":"120","author":"DC Anthony","year":"1997","unstructured":"Anthony DC, Bolton SJ, Fearn S, Perry VH (1997) Age-related effects of interleukin-1 beta on polymorphonuclear neutrophil-dependent increases in blood\u2013brain barrier permeability in rats. Brain 120:435\u2013444","journal-title":"Brain"},{"key":"8618_CR63","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-5728(96)00179-8","volume":"72","author":"S Chandler","year":"1997","unstructured":"Chandler S, Miller KM, Clements JM et al (1997) Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview. J Neuroimmunol 72:155\u2013161","journal-title":"J Neuroimmunol"},{"key":"8618_CR64","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/s004010050754","volume":"94","author":"JA Cossins","year":"1997","unstructured":"Cossins JA, Clements JM, Ford J et al (1997) Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions. Acta Neuropathol (Berl) 94:590\u2013598","journal-title":"Acta Neuropathol (Berl)"},{"key":"8618_CR65","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/brain\/121.1.159","volume":"121","author":"BC Kieseier","year":"1998","unstructured":"Kieseier BC, Kiefer R, Clements JM et al (1998) Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis. Brain 121:159\u2013166","journal-title":"Brain"},{"key":"8618_CR66","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/00005072-199809000-00005","volume":"57","author":"F Umehara","year":"1998","unstructured":"Umehara F, Okada Y, Fujimoto N, Abe M, Izumo S, Osame M (1998) Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-1-associated myelopathy. J Neuropathol Exp Neurol 57:839\u2013849","journal-title":"J Neuropathol Exp Neurol"},{"key":"8618_CR67","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0166-2236(97)01169-7","volume":"21","author":"VW Yong","year":"1998","unstructured":"Yong VW, Krekoski CA, Forsyth PA, Bell R, Edwards DR (1998) Matrix metalloproteinases and diseases of the CNS. Trends Neurosci 21:75\u201380 [Review]","journal-title":"Trends Neurosci"},{"key":"8618_CR68","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1128\/IAI.68.2.615-620.2000","volume":"68","author":"SL Leib","year":"2000","unstructured":"Leib SL, Leepert D, Clements J, Tauber MG (2000) Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis. Infect Immun 68:615\u2013620","journal-title":"Infect Immun"},{"key":"8618_CR69","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1474-4422(09)70016-X","volume":"8","author":"GA Rosenberg","year":"2009","unstructured":"Rosenberg GA (2009) Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol 8:205\u2013216","journal-title":"Lancet Neurol"},{"key":"8618_CR70","author":"F Dal-Pizzol","year":"2013","unstructured":"Dal-Pizzol F, Rojas HA, dos Santos EM et al (2013) Matrix metalloproteinase-2 and metalloproteinase-9 activities are associated with blood\u2013brain barrier dysfunction in an animal model of severe sepsis. Mol Neurobiol. doi: 10.1007\/s12035-013-8433-7","journal-title":"Mol Neurobiol"},{"key":"8618_CR71","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1227\/01.NEU.0000351768.11363.48","volume":"65","author":"M Grossetete","year":"2009","unstructured":"Grossetete M, Phelps J, Arko L, Yonas H, Rosenberg GA (2009) Elevation of matrix metalloproteinases 3 and 9 in cerebrospinal fluid and blood in patients with severe traumatic brain injury. Neurosurgery 65:702\u2013708","journal-title":"Neurosurgery"},{"key":"8618_CR72","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1161\/01.RES.85.10.906","volume":"85","author":"C Fernandez-Patron","year":"1999","unstructured":"Fernandez-Patron C, Radomski MW, Davidge ST (1999) Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor. Circ Res 85:906\u2013911","journal-title":"Circ Res"},{"key":"8618_CR73","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1167\/iovs.06-1138","volume":"48","author":"S He","year":"2007","unstructured":"He S, Prasanna G, Yorio T (2007) Endothelin-1-mediated signaling in the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in astrocytes. Investig Ophthalmol Vis Sci 48:3737\u20133745","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"8618_CR74","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1523\/JNEUROSCI.22-03-00920.2002","volume":"22","author":"A Szklarczyk","year":"2002","unstructured":"Szklarczyk A, Lapinska J, Rylski M, McKay RD, Kaczmarek L (2002) Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus. J Neurosci 22:920\u2013930","journal-title":"J Neurosci"},{"key":"8618_CR75","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/sj.cdd.4402141","volume":"14","author":"P Michaluk","year":"2007","unstructured":"Michaluk P, Kaczmarek L (2007) Matrix metalloproteinase-9 in glutamatedependent adult brain function and dysfunction. Cell Death Differ 14:1255\u20131258","journal-title":"Cell Death Differ"},{"key":"8618_CR76","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2174\/157015909790031157","volume":"7","author":"X Dong","year":"2009","unstructured":"Dong X, Song YN, Liu WG, Guo XL (2009) Mmp-9, a potential target for cerebral ischemic treatment. Curr Neuropharmacol 7:269\u2013275","journal-title":"Curr Neuropharmacol"},{"key":"8618_CR77","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.mehy.2010.09.013","volume":"76","author":"P Yin","year":"2011","unstructured":"Yin P, Yang L, Zhou HY, Sun RP (2011) Matrix metalloproteinase-9 may be a potential therapeutic target in epilepsy. Med Hypotheses 76:184\u2013186","journal-title":"Med Hypotheses"},{"key":"8618_CR78","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1742-2094-9-68","volume":"9","author":"H Ralay Ranaivo","year":"2012","unstructured":"Ralay Ranaivo H, Hodge JN, Choi N, Wainwright MS (2012) Albumin induces upregulation of matrix metalloproteinase-9 in astrocytes via MAPK and reactive oxygen species-dependent pathways. J Neuroinflammation 9:68","journal-title":"J Neuroinflammation"},{"key":"8618_CR79","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0165-0173(01)00101-1","volume":"36","author":"D Leppert","year":"2001","unstructured":"Leppert D, Lindberg RLP, Kappos L, Leib S (2001) Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis. Brain Res Rev 36:249\u2013257","journal-title":"Brain Res Rev"},{"key":"8618_CR80","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0165-5728(95)00148-4","volume":"64","author":"HE Vries de","year":"1996","unstructured":"de Vries HE, Blom-Roosemalen MC, van Oosten M, de Boer AG, van Berkel TJ, Breimer DD, Kuiper J (1996) The influence of cytokines on the integrity of the blood\u2013 brain barrier in vitro. J Neuroimmunol 64:37\u201343","journal-title":"J Neuroimmunol"},{"key":"8618_CR81","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nature01320","volume":"420","author":"C Nathan","year":"2002","unstructured":"Nathan C (2002) Points of control in inflammation. Nature 420:846\u2013852","journal-title":"Nature"},{"key":"8618_CR82","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nature01321","volume":"420","author":"KJ Tracey","year":"2002","unstructured":"Tracey KJ (2002) The inflammatory reflex. Nature 420:853\u2013859","journal-title":"Nature"},{"key":"8618_CR83","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2174\/1381612053381684","volume":"11","author":"WA Banks","year":"2005","unstructured":"Banks WA (2005) Blood\u2013brain barrier transport of cytokines: a mechanism for neuropathology. Curr Pharm Des 11:973\u2013984","journal-title":"Curr Pharm Des"},{"key":"8618_CR84","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0166-2236(90)90043-A","volume":"13","author":"W Risau","year":"1990","unstructured":"Risau W, Wolburg H (1990) Development of the blood\u2013brain barrier. Trends Neurosci 13:174\u2013178","journal-title":"Trends Neurosci"},{"key":"8618_CR85","doi-asserted-by":"crossref","first-page":"H1531","DOI":"10.1152\/ajpheart.00027.2002","volume":"283","author":"JD Huber","year":"2002a","unstructured":"Huber JD, Hau VS, Borg L, Campos CR, Egleton RD, Davis TP (2002a) Blood\u2013brain barrier tight junctions are altered during a 72-h exposure to lambda-carrageenan-induced inflammatory pain. Am J Physiol Heart Circ Physiol 283:H1531\u2013H1537","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"8618_CR86","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0014-2999(02)02150-7","volume":"450","author":"JD Huber","year":"2002b","unstructured":"Huber JD, Hau VS, Mark KS, Brown RC, Campos CR, Davis TP (2002b) Viability of microvascular endothelial cells to direct exposure of formalin, lambda-carrageenan, and complete Freund\u2019s adjuvant. Eur J Pharmacol 450:297\u2013304","journal-title":"Eur J Pharmacol"},{"key":"8618_CR87","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.bbadis.2013.02.001","volume":"1832","author":"R Simone de","year":"2013","unstructured":"de Simone R, Vissicchio F, Mingarelli C et al (2013) Branched-chain amino acids influence the immune properties of microglial cells and their responsiveness to pro-inflammatory signals. Biochim Biophys Acta 1832:650\u2013659","journal-title":"Biochim Biophys Acta"},{"key":"8618_CR88","first-page":"151","volume":"378","author":"H Nagase","year":"1997","unstructured":"Nagase H (1997) Activation mechanisms of matrix metalloproteinases. Biol Chem 378:151\u2013160","journal-title":"Biol Chem"},{"key":"8618_CR89","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1126\/science.1073634","volume":"297","author":"Z Gu","year":"2002","unstructured":"Gu Z, Kaul M, Yan B et al (2002) S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 297:1186\u20131190","journal-title":"Science"},{"key":"8618_CR90","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nrc884","volume":"2","author":"CM Overall","year":"2002","unstructured":"Overall CM, Lopez-Otin C (2002) Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2:657\u2013672","journal-title":"Nat Rev Cancer"},{"key":"8618_CR91","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1080\/10715760902751902","volume":"43","author":"PB Pun","year":"2009","unstructured":"Pun PB, Lu J, Moochhala S (2009) Involvement of ROS in BBB dysfunction. Free Radic Res 43:348\u2013364","journal-title":"Free Radic Res"},{"key":"8618_CR92","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0006-8993(00)03247-9","volume":"896","author":"H Xaio","year":"2001","unstructured":"Xaio H, Banks WA, Niehoff ML, Morley JE (2001) Effect of LPS on the permeability of the blood\u2013brain barrier to insulin. Brain Res 896:36\u201342","journal-title":"Brain Res"},{"key":"8618_CR93","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.tox.2004.04.015","volume":"201","author":"AK Singh","year":"2004","unstructured":"Singh AK, Jiang Y (2004) How does peripheral lipopolysaccharide induce gene expression in the brain of rats? Toxicology 201:197\u2013207","journal-title":"Toxicology"},{"key":"8618_CR94","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0165-5728(98)00004-6","volume":"85","author":"U Bickel","year":"1998","unstructured":"Bickel U, Grave B, Kang YS, del Rey A, Voigt K (1998) No increase in blood\u2013brain barrier permeability after intraperitoneal injection of endotoxin in the rat. J Neuroimmunol 85:131\u2013136","journal-title":"J Neuroimmunol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-013-8618-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-013-8618-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-013-8618-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T14:51:44Z","timestamp":1647874304000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-013-8618-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,5]]},"references-count":94,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["8618"],"URL":"https:\/\/doi.org\/10.1007\/s12035-013-8618-0","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,5]]}}}